Cubist Systematic Strategies LLC increased its stake in Afya Limited (NASDAQ:AFYA – Free Report) by 136.9% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 35,254 shares of the company’s stock after purchasing an additional 20,370 shares during the quarter. Cubist Systematic Strategies LLC’s holdings in Afya were worth $622,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in AFYA. Marshall Wace LLP increased its holdings in Afya by 41.8% in the 2nd quarter. Marshall Wace LLP now owns 336,985 shares of the company’s stock valued at $5,948,000 after acquiring an additional 99,416 shares during the last quarter. Millennium Management LLC boosted its stake in shares of Afya by 45.0% during the 2nd quarter. Millennium Management LLC now owns 291,164 shares of the company’s stock worth $5,139,000 after purchasing an additional 90,383 shares during the period. Renaissance Technologies LLC boosted its stake in shares of Afya by 19.7% during the 2nd quarter. Renaissance Technologies LLC now owns 266,500 shares of the company’s stock worth $4,704,000 after purchasing an additional 43,800 shares during the period. Finally, Lifestyle Asset Management Inc. boosted its stake in shares of Afya by 26.9% during the 2nd quarter. Lifestyle Asset Management Inc. now owns 14,784 shares of the company’s stock worth $261,000 after purchasing an additional 3,133 shares during the period. Hedge funds and other institutional investors own 88.02% of the company’s stock.
Afya Price Performance
Afya stock opened at $16.27 on Friday. The company has a 50-day moving average price of $17.00 and a 200 day moving average price of $17.36. The stock has a market cap of $1.52 billion, a P/E ratio of 13.45, a PEG ratio of 0.45 and a beta of 0.92. Afya Limited has a 12-month low of $14.64 and a 12-month high of $22.48. The company has a current ratio of 1.47, a quick ratio of 1.47 and a debt-to-equity ratio of 0.40.
Analyst Upgrades and Downgrades
Several brokerages have recently weighed in on AFYA. Morgan Stanley lowered their price target on shares of Afya from $21.00 to $19.00 and set an “equal weight” rating for the company in a research report on Friday, June 21st. UBS Group began coverage on shares of Afya in a research note on Friday, August 30th. They set a “neutral” rating and a $19.50 price target on the stock.
View Our Latest Research Report on Afya
Afya Profile
Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.
Further Reading
- Five stocks we like better than Afya
- Utilities Stocks Explained – How and Why to Invest in Utilities
- 3 Mid-Cap Stocks Under $20 With Insider Buying and Major Upside
- What is Insider Trading? What You Can Learn from Insider Trading
- China’s EV Rally: Should Investors Chase, Avoid, or Buy the Dip?
- How to Calculate Options Profits
- MarketBeat Week in Review – 10/7 – 10/11
Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.